A recent study found that markers of higher insulin resistance, including triglyceride, are consistently associated with reduced glycemic response to DPP-4 inhibitors in T2DM patients with DPP-4 inhibitor monotherapy [8]. This evidence concerns the gene DPP4 and Insulin resistance.